Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Tobacco Use Disorder 4Uterine Cervical Neoplasms 3Neoplasms 3Breast Neoplasms 3Tobacco Use Cessation 2Smoking Cessation 2Smoking 2Lung Neoplasms 2Head and Neck Neoplasms 2Cigarette Smoking 2Carcinoma, Non-Small-Cell Lung 2Urinary Bladder Neoplasms 1Tongue Neoplasms 1Tobacco Use 1Tobacco Smoking 1Stomach Neoplasms 1Small Cell Lung Carcinoma 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Oropharyngeal Neoplasms 1Nasopharyngeal Neoplasms 1Mouth Neoplasms 1Liver Neoplasms 1Leukemia, Myeloid, Acute 1Leukemia 1Laryngeal Neoplasms 1Kidney Neoplasms 1Hypopharyngeal Neoplasms 1Health Education 1Hand-Foot Syndrome 1

Interventions

Vincristine 1VGX-3100 1Tobacco Use Cessation Devices 1Surveys and Questionnaires 1Rituximab 1Prednisone 1Etoposide 1Electroporation Therapies 1Electroporation 1Doxorubicin 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × HIV Seropositivity × Tobacco Use Cessation Devices × Clear all
NCT02302859 2020-01-27

Mobile Media-Rich Interactive Guideline System (MMRIGS) Pilot Study

M.D. Anderson Cancer Center

Phase NA Terminated
8 enrolled 3 charts

Acquired Immunodeficiency Syndrome, HIV Seropositivity, Tobacco Use Cessation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡